Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the biodefense market right now?

The biodefense market has grown strongly in recent years. It will rise from $18.55 billion in 2024 to $20.29 billion in 2025, at a CAGR of 9.4%. Key factors behind this growth include heightened government investment in biodefense programs, strengthened regulatory frameworks to fast-track biodefense product approvals, enhanced collaboration between governments, private sectors, and academic institutions, and increasing concerns over bioterrorism and geopolitical tensions.

How fast Is the biodefense market expected to grow, and what’s its future value?

The biodefense market is expected to grow to $28.75 billion by 2029, at a CAGR of 9.1%. Growth is attributed to emerging infectious diseases, biotech breakthroughs, stronger international collaboration and funding, upgrading biodefense infrastructure, growing public awareness, evolving policies, and increased private sector investment. Key trends include AI and machine learning for predictive modeling, threat detection, next-gen vaccines and therapeutics, AI-driven drug discovery, and improved genomic surveillance.

Get your biodefense market report here!

https://www.thebusinessresearchcompany.com/report/biodefense-global-market-report

What are the leading drivers of growth in the biodefense market?

The recurrent threat of emerging infectious diseases is expected to spur the growth of the biodefense market. These diseases, caused by microorganisms like viruses and bacteria, highlight the need for effective preparedness and rapid response. Biodefense measures, which focus on early detection and response, are vital in managing these health threats. For example, the WHO estimated 10.6 million cases of tuberculosis worldwide in 2022, underscoring the growing demand for biodefense solutions.

What are the key segments defining the biodefense market?

The biodefense market covered in this report is segmented –

1) By Type: Anthrax, Smallpox, Botulism, Radiation Or Nuclear, Other Types

2) By Biothreat Detection Device: Samplers, Detectors Or Triggering Devices, Identifiers, Assays, Other Biothreat Detection Devices

3) By Application: Hospitals And Clinics, Ambulatory Care Centers, Other Applications

Subsegments:

1) By Anthrax: Bacillus Anthracis Vaccine, Anthrax Therapeutics

2) By Smallpox: Smallpox Vaccine, Antiviral Drugs For Smallpox

3) By Botulism: Botulism Antitoxin, Botulism Vaccine, Botulinum Neurotoxin Inhibitors

4) By Radiation Or Nuclear: Radiation Protection Drugs, Medical Countermeasures

5) By Other Types: Ricin, Plague, Tularemia, Viral Hemorrhagic Fevers, Other Biotoxins Or Biothreat Agents

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15993&type=smp

Who are the key players steering the development of the biodefense market?

Major companies operating in the biodefense market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals

What emerging trends are influencing the growth of the biodefense market?

Companies in the biodefense market are innovating solutions such as nasal COVID-19 vaccines to strengthen global preparedness against biological threats. Nasal vaccines offer easier administration, potential mucosal immunity, and less reliance on needles, improving accessibility and immune response. For instance, in January 2023, Bharat Biotech International Limited from India launched the iNCOVACC Nasal COVID-19 vaccine, using a recombinant adenovirus vector and pre-fusion stabilized spike protein. The vaccine, after successful clinical trials, is administered as nasal drops in a two-dose series, providing a user-friendly alternative to traditional injections.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15993

Which regions are most influential in expanding the biodefense market?

North America was the largest region in the biodefense market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodefense market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Synthetic Biology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

Biobanks

https://www.thebusinessresearchcompany.com/report/biobanks-market

Biostimulants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biostimulants-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: